The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fludeoxyglucose (18F) Radionuclide Injection Market Research Report 2024
Synopsis
Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
The global Fludeoxyglucose (18F) Radionuclide Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
This report aims to provide a comprehensive presentation of the global market for Fludeoxyglucose (18F) Radionuclide Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fludeoxyglucose (18F) Radionuclide Injection.
Report Scope
The Fludeoxyglucose (18F) Radionuclide Injection market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fludeoxyglucose (18F) Radionuclide Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fludeoxyglucose (18F) Radionuclide Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zevacor Pharma
Queen's PET Imaging
Triad Isotopes
NCM USA Bronx
Spectron MRC
Petnet Solutions
Shertech Laboratories
Precision Nuclear
Segment by Type
Sterile
Non-sterile
Segment by Application
Hospitals
Clinics
Diagnostics Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fludeoxyglucose (18F) Radionuclide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fludeoxyglucose (18F) Radionuclide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
The global Fludeoxyglucose (18F) Radionuclide Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
This report aims to provide a comprehensive presentation of the global market for Fludeoxyglucose (18F) Radionuclide Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fludeoxyglucose (18F) Radionuclide Injection.
Report Scope
The Fludeoxyglucose (18F) Radionuclide Injection market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fludeoxyglucose (18F) Radionuclide Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fludeoxyglucose (18F) Radionuclide Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zevacor Pharma
Queen's PET Imaging
Triad Isotopes
NCM USA Bronx
Spectron MRC
Petnet Solutions
Shertech Laboratories
Precision Nuclear
Segment by Type
Sterile
Non-sterile
Segment by Application
Hospitals
Clinics
Diagnostics Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fludeoxyglucose (18F) Radionuclide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fludeoxyglucose (18F) Radionuclide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fludeoxyglucose (18F) Radionuclide Injection Market Overview
1.1 Product Overview and Scope of Fludeoxyglucose (18F) Radionuclide Injection
1.2 Fludeoxyglucose (18F) Radionuclide Injection Segment by Type
1.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Value Comparison by Type (2024-2030)
1.2.2 Sterile
1.2.3 Non-sterile
1.3 Fludeoxyglucose (18F) Radionuclide Injection Segment by Application
1.3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostics Center
1.4 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size Estimates and Forecasts
1.4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue 2019-2030
1.4.2 Global Fludeoxyglucose (18F) Radionuclide Injection Sales 2019-2030
1.4.3 Global Fludeoxyglucose (18F) Radionuclide Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fludeoxyglucose (18F) Radionuclide Injection Market Competition by Manufacturers
2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fludeoxyglucose (18F) Radionuclide Injection Average Price by Manufacturers (2019-2024)
2.4 Global Fludeoxyglucose (18F) Radionuclide Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fludeoxyglucose (18F) Radionuclide Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fludeoxyglucose (18F) Radionuclide Injection, Product Type & Application
2.7 Fludeoxyglucose (18F) Radionuclide Injection Market Competitive Situation and Trends
2.7.1 Fludeoxyglucose (18F) Radionuclide Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fludeoxyglucose (18F) Radionuclide Injection Players Market Share by Revenue
2.7.3 Global Fludeoxyglucose (18F) Radionuclide Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fludeoxyglucose (18F) Radionuclide Injection Retrospective Market Scenario by Region
3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Region: 2019-2030
3.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Region: 2019-2024
3.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Region: 2025-2030
3.3 Global Fludeoxyglucose (18F) Radionuclide Injection Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region: 2019-2030
3.3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region: 2019-2024
3.3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Region: 2025-2030
3.4 North America Fludeoxyglucose (18F) Radionuclide Injection Market Facts & Figures by Country
3.4.1 North America Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2019-2030)
3.4.3 North America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fludeoxyglucose (18F) Radionuclide Injection Market Facts & Figures by Country
3.5.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2019-2030)
3.5.3 Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fludeoxyglucose (18F) Radionuclide Injection Market Facts & Figures by Country
3.7.1 Latin America Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2019-2030)
3.7.3 Latin America Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2019-2030)
4.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2019-2024)
4.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Type (2025-2030)
4.1.3 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Type (2019-2030)
4.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type (2019-2030)
4.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type (2019-2024)
4.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type (2025-2030)
4.2.3 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Type (2019-2030)
4.3 Global Fludeoxyglucose (18F) Radionuclide Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2019-2030)
5.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2019-2024)
5.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Sales by Application (2025-2030)
5.1.3 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application (2019-2030)
5.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Application (2019-2030)
5.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Application (2019-2024)
5.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Application (2025-2030)
5.2.3 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue Market Share by Application (2019-2030)
5.3 Global Fludeoxyglucose (18F) Radionuclide Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zevacor Pharma
6.1.1 Zevacor Pharma Corporation Information
6.1.2 Zevacor Pharma Description and Business Overview
6.1.3 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Product Portfolio
6.1.5 Zevacor Pharma Recent Developments/Updates
6.2 Queen's PET Imaging
6.2.1 Queen's PET Imaging Corporation Information
6.2.2 Queen's PET Imaging Description and Business Overview
6.2.3 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Product Portfolio
6.2.5 Queen's PET Imaging Recent Developments/Updates
6.3 Triad Isotopes
6.3.1 Triad Isotopes Corporation Information
6.3.2 Triad Isotopes Description and Business Overview
6.3.3 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Product Portfolio
6.3.5 Triad Isotopes Recent Developments/Updates
6.4 NCM USA Bronx
6.4.1 NCM USA Bronx Corporation Information
6.4.2 NCM USA Bronx Description and Business Overview
6.4.3 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Product Portfolio
6.4.5 NCM USA Bronx Recent Developments/Updates
6.5 Spectron MRC
6.5.1 Spectron MRC Corporation Information
6.5.2 Spectron MRC Description and Business Overview
6.5.3 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Product Portfolio
6.5.5 Spectron MRC Recent Developments/Updates
6.6 Petnet Solutions
6.6.1 Petnet Solutions Corporation Information
6.6.2 Petnet Solutions Description and Business Overview
6.6.3 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Product Portfolio
6.6.5 Petnet Solutions Recent Developments/Updates
6.7 Shertech Laboratories
6.6.1 Shertech Laboratories Corporation Information
6.6.2 Shertech Laboratories Description and Business Overview
6.6.3 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Product Portfolio
6.7.5 Shertech Laboratories Recent Developments/Updates
6.8 Precision Nuclear
6.8.1 Precision Nuclear Corporation Information
6.8.2 Precision Nuclear Description and Business Overview
6.8.3 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Product Portfolio
6.8.5 Precision Nuclear Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fludeoxyglucose (18F) Radionuclide Injection Industry Chain Analysis
7.2 Fludeoxyglucose (18F) Radionuclide Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fludeoxyglucose (18F) Radionuclide Injection Production Mode & Process
7.4 Fludeoxyglucose (18F) Radionuclide Injection Sales and Marketing
7.4.1 Fludeoxyglucose (18F) Radionuclide Injection Sales Channels
7.4.2 Fludeoxyglucose (18F) Radionuclide Injection Distributors
7.5 Fludeoxyglucose (18F) Radionuclide Injection Customers
8 Fludeoxyglucose (18F) Radionuclide Injection Market Dynamics
8.1 Fludeoxyglucose (18F) Radionuclide Injection Industry Trends
8.2 Fludeoxyglucose (18F) Radionuclide Injection Market Drivers
8.3 Fludeoxyglucose (18F) Radionuclide Injection Market Challenges
8.4 Fludeoxyglucose (18F) Radionuclide Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
